Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 3

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 3
---
 Nasdaq under the symbol “BIVIW.”
On October 2, 2025, the last reported sales price of our Common Stock on Nasdaq was $2.00 per share and the last reported sales price
of our Warrants on Nasdaq was $0.44 per share.

Investing in our Common Stock involves a high degree of risk. See “Risk Factors” beginning on page 7.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of the disclosures in the prospectus . Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is ,
2025</div>

<div align='center'>Table of Contents</div>

| About This Prospectus                                |  1 |
| Prospectus Summary                                   |  2 |
| The Offering                                         |  6 |
| Risk Factors                                         |  7 |
| Cautionary Note Regarding Forward-Looking Statements | 11 |
| Use of Proceeds                                      | 12 |
| Dividend Policy                                      | 13 |
| Securities Market Information                        | 14 |
| Description of Securities                            | 15 |
| Plan of Distribution                                 | 20 |
| Legal Matters                                        | 21 |
| Experts                                              | 21 |
| Where You Can Find More Information                  | 21 |
| Incorporation of Documents by Reference              | 21 |

<div align='center'>ABOUT THIS PROSPECTUS</div>

The registration statement we filed with the Securities
and Exchange Commission (the “SEC”) includes exhibits that provide more detail of the matters discussed in this prospectus.
You should read this prospectus, the related exhibits filed with the SEC, and the documents incorporated by reference herein before making
your investment decision. You should rely only on the information provided in this prospectus and the documents incorporated by reference
herein or any amendment thereto. You should not assume that the information contained in this prospectus or any related free writing prospectus
is accurate on any date subsequent to the date set forth on the front of the document or that any information we have incorporated by
reference herein is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus
or any related free writing prospectus is delivered, or securities are sold, on a later date. This prospectus contains or incorporates
by reference summaries of certain provisions contained in some of the documents described herein, but